COc1ccc(CCNc2c([N+](=O)[O-])nn(-c3cccc(C)c3)[n+]2[O-])cc1OC
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?